Postdoctoral researcher for the Cardiac tissue engineering and regenerative therapies

CNIC - Spanish National Center for Cardiovascular Research / Centro Nac. Investigaciones Cardiovasc.; Madrid; Presencial; EUR 38.000 - 50.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Immediate incorporation

Descripción de la vacante

CNIC in Madrid seeks a postdoctoral researcher to advance regenerative therapies for heart repair. You will culture iPS cells, work with animal models, and apply molecular biology, imaging, and data analysis in a multidisciplinary setting.

Funded by the EU through the HeartVISION project (EIC Pathfinder Open 2025). The process includes an English interview; immediate incorporation is encouraged under a merit-based recruitment system.

Formación

• PhD in life sciences required.
• At least one first-author publication in cardiovascular research.
• Experience with cardiovascular experimental models is highly valued.

Responsabilidades

• Train in regenerative therapies to improve cardiomyocyte engraftment.
• Culture iPS cells and differentiate to cardiac lineages.
• Work with animal models; perform molecular biology and imaging analyses; analyze data.

Educación

PhD in life sciences

First-author publication in cardiovascular research

Herramientas

Echocardiography

ECG analysis

Fluorescence microscopy

Gene therapy studies

Descripción del empleo

Status

Open call

Deadline For Submitting Applications

Wednesday, 23 September, 2026

The Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) CNIC has been conceived to develop research of excellence, competitive and of international relevance in relation to cardiovascular diseases. The CNIC has a research centre of 24,000 m2, located in Madrid, with more than 6,000 m2 for laboratories equipped with a state‑of‑the‑art infrastructure and equipment.

Functions

The selected candidate will get training in engineering regenerative therapies to improve cardiomyocyte engraftment in an injured heart. Work will involve the culture of iPS cells, animal models, use of molecular and biology techniques and microscopy techniques as well as data analysis.

This contract is funded by the European Union through the European Innovation Council, with funding awarded under the EIC Pathfinder Open 2025 call, Project GA 101258941 and acronym HeartVISION.

Mandatory Requirements

• PhD in the area of life science
• At least one first author publication in the cardiovascular research field is required

Valuable Requirements

• C1. Experience in cardiovascular experimental models, including echocardiography and ECG analysis.
• C2. Accreditation for functions B and C in experimental models.
• C3. Experience with gene therapy studies including studies with adeno‑associated viruses, in cell culture including human pluripotent stem cell culture and cardiac differentiation from induced pluripotent stem cells.
• C4. Experience in fluorescence microscopy and image analysis.
• C5. Interview (it will be conducted in English).

Positive action: a correction index of 1.5 is established for each year of experience in the evaluation of the number of years in those criteria where experience is evaluated, in the event that the disable person greater than 66% and 1.2 in the event that the disable person greater than 33%.

We Offer

• Joining a modern Research Center of international relevance in the scientific field.
• Integration into young teams in an environment of scientific excellence.
• Access to a modern infrastructure with the most advanced technology
• Training in the latest advances, both technical and scientific.
• “Contrato de actividades científico‑técnicas, de duración indefinida”, in accordance with Article 23‑bis “de la Ley de la Ciencia, la Tecnología y la Innovación (texto refundido Ley 14/2011, de 1 de junio, de la Ciencia, la Tecnología y la Innovación)”, funded by EIC Pathfinder Open 2025 call, Project GA 101258941 and acronym HeartVISION, as long as the selected candidate complies with the legal requirements for the formalization of the contract in accordance with the Spanish labor law.
• Immediate incorporation

Recruiment Plan

The RESOLUTION OF THE SECRETARIAT OF STATE FOR PUBLIC FUNCTION APPROVING THE COMMON ACTION CRITERIA FOR THE RECRUITMENT PROCESSES IN THE STATE PUBLIC SECTOR ENTITIES of April 11, 2022, sets forth in point 6.1 that “Unless a specific regulation establishes a merit‑bases recruitment system (“concurso”), the competition (“concurso‑oposición”) must be the recruitment system”.

In CNIC, the specific regulations approved by the Foundation's board of trustees establish a merit‑based recruitment system (“concurso”) including a personal interview.

At least three candidates with the highest score (as long as they reach the minimum of 60 points as a sum of criteria (C1‑C4) will be interviewed. The candidate with the highest score will be hired given the total score (C1‑C5) reaches 75 points

Recruitment Commission

• Head of the Group “Cardiac tissue engineering and regenerative therapies”
• Posdoc researcher
• Manager, Research Office
• Manager, Research Office
• HR member

The CNIC guarantees, in its field of action, the principle of equality in access to employment, and cannot establish any discrimination, direct or indirect, based on reasons of origin, including racial or ethnic, sex, age, marital status, religion or convictions, political opinion, sexual orientation and identity, gender expression, sexual characteristics, union affiliation, social condition, language within the State and disability, provided that the workers are in conditions of aptitude to carry out the work or employment for which try they are assigned.

By participating in the selection process, the participant agrees that their data appear in the public resolutions of the selection process. Such resolutions (provisional list of admitted and excluded, definitive list of admitted and excluded and resolution of the process) are published on the CNIC website.

In accordance with Regulation (EU) 2016/679 (GDPR) and Ley Orgánica 3/2018, de 5 de diciembre, de Protección de Datos Personales y garantía de los derechos digitales (LOPD‑GDD), your personal data will be processed by CNIC solely for the purpose of managing your application and retained for the duration of the selection process. You may exercise your data protection rights by contacting the CNIC Data Protection Officer ([e-mail])

Score Criteria

C1. Experience in cardiovascular experimental models, including echocardiography and ECG analysis (it will be assessed globally considering the time/specialization relationship and number of known techniques).

20%

C2. Accreditation for functions B and C in experimental models (it will be assessed according to the official documentation provided).

10%

C3. Experience with gene therapy studies including studies with adeno‑associated viruses, in cell culture including human pluripotent stem cell culture and cardiac differentiation from induced pluripotent stem cells (it will be assessed globally considering the time/specialization relationship and number of known techniques).

30%

C4. Experience in fluorescence microscopy and image analysis (it will be assessed globally considering the time/specialization relationship and number of known techniques).

20%

C5. Interview (it will be conducted in English).

20%

Scoring Criteria

C1 - Experience in cardiovascular experimental models, including echocardiography and ECG analysis - 20%

C2 - Accreditation for functions B and C in experimental model ssessed according to the official documentation provided) - 10%

C3 - Experience with gene therapy studies, in cell culture and cardiac differentiation from induced pluripotent stem - 30%

C4 - Experience in fluorescence microscopy and image analysis - 20%

C5 - Interview - 20%

"In the event of absence of any of the evaluators an alternate evaluator of the same area will be appointed"

C1 - Experience in cardiovascular experimental models, including echocardiography and ECG analysis - 20%

C2 - Accreditation for functions B and C in experimental model ssessed according to the official documentation provided) - 10%

C3 - Experience with gene therapy studies, in cell culture and cardiac differentiation from induced pluripotent stem - 30%

C4 - Experience in fluorescence microscopy and image analysis - 20%

C5 - Interview - 20%